A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to mFOLFOX6
Related studies linked through entity extraction aliases.
Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
- Status
- RECRUITING
- Phase
- PHASE3
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Total Neoadjuvant Therapy in Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC
- Status
- UNKNOWN
- Phase
- PHASE3
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2